OUR
PLATFORM
A transcription factor-based platform that turns iPSCs into functional, assay-ready human cells in days, built to accelerate drug discovery.
QUICK-TISSUE™ DIFFERENTIATION
PLATFORM
Ricoh Biosciences employs a systematic, transcription factor-driven approach to generate functional cells from iPSCs with precision for research, screening, therapeutic development, and more.
Target Phenotype Definition
Define mature cell characteristics:
- Transcriptomic profiles
- Phenotypic markers
- Functional assays
- Customer endpoints
Transcription Factor Selection
Eliminate trial-and-error approaches using the proprietary Human Gene Correlation Matrix to systematically test transcription factor combinations that guide cell lineage specifications.
Cell Culture Optimization
Refine and standardize differentiation protocols:
- Media formulations
- Small molecule timing
- Maturation parameters
- Subtype specificity
Cell Production & Delivery
Validated protocols scaled for manufacturing:
- Cryopreservation
- QC documentation
- Ready-to-use delivery
- Donor reproducibility
Our Core Technology
Our core technologies combine computational precision with biological insight to drive reproducible, clinically relevant outcomes.
Rapidly identify and select transcription factors for optimized differentiation based on our proprietary, large-scale transcriptomic database.
This multi-omic atlas lets us predict and validate transcription factor cocktails in silico, then confirm them at scale, streamlining and accelerating the development of relevant cell lineages to power your program.
Accelerate experimental timelines and increase throughput with our rapid, non-integrating differentiation technology.
From target validation to candidate screening, safety testing, and disease modeling, our platform accelerates every stage of the discovery pipeline. Quick-Tissue™ enables reproducible, non-integrating differentiation, producing high-quality human cells in days instead of weeks. This speed and reliability empower researchers to make faster, safer, and more confident decisions.
Decades of experience in a wide variety of downstream applications.
At Ricoh Biosciences, we bring together decades of expertise across biotechnology, pharmaceuticals, data science, and translational research to help you move programs forward with confidence.
When you partner with us, you don’t just get a service provider, you gain an extension of your discovery and development team. Our scientists collaborate seamlessly with yours to:
- Accelerate decision-making through data-driven experimental design and strategic scientific insight.
- Reduce development risk via integrated project execution from concept through clinical translation.
- Deliver reproducible, decision-ready data with innovative assay development, optimization, and advanced analytics.
What Our Platform
Enables
From custom differentiation to scalable cell therapy development, our iPSC platform is engineered for every stage of your discovery and preclinical pipeline.
Custom iPSC Differentiation
Tailored differentiation protocols to convert iPSCs or ESCs into specific human cell types based on our proprietary transcription factor-based differentiation technology.
- Compatible with any iPSC line, including patient-derived lines
- Broad range of neuronal and glial cell types
- Disease-relevant and functionally validated customization
Novel Cell Type Development
Design and validation of entirely new differentiation routes for previously unavailable cell lineages and subtypes through systematic transcription factor discovery.
- Optimal transcription factor identification
- Custom medium formulation
- Partnership-driven innovation
Disease Modeling & Functional Assays
Integrated services combining patient-derived iPSC models with differentiation into disease-relevant cell types and comprehensive functional validation.
- Patient-specific disease models and complex humanized systems
- Multi-cell type disease panels and functional endpoint assays
- Enables predictive, translational insights for drug discovery
Cell Therapy Development
Scalable and robust pipeline for off-the-shelf allogeneic cell therapies designed for regenerative medicine and immune-based therapeutic applications.
- Shorter manufacturing timelines through automation
- Ready-to-use, universal donor iPSC-derived products
- Clear clinical translation pathway from research to therapy
Platform Benefits
From Idea to Insight,
in Weeks.
Cut differentiation timelines dramatically to accelerate discovery.
Flexibility to Model What Matters Most.
Access rare or disease-relevant cell types on-demand.
Reliable Insights You
Can Trust.
Ensure reproducibility and consistency across studies.
Speak to a Scientist Today
Our team is here to help you unlock the full potential of our platform. Whether you want to explore collaborations, our technologies, or discuss your specific research needs, connect with a knowledgeable scientist today.
Online Marketplaces
Our products and services are available through ScienceExchange and Scientist.com for efficient, compliant procurement with existing vendor frameworks.
"*" indicates required fields